Birth Control for PCOS: What It Treats, What It Masks, and Which Pill

What Does the Combined Pill Actually Treat?

A 2020 Cochrane review of 44 trials in 2,253 women with PCOS found the combined pill improved hirsutism by a mean of 1.92 points on the Ferriman-Gallwey score compared with metformin, in women with a BMI of 25–30 kg/m². That is the evidence the 2023 international guideline rated low-quality and used for a first-line label the guideline applies to the combined pill for menstrual irregularity and hyperandrogenism — while rating the recommendation behind it very-low-certainty, and favouring metformin instead where the goal is metabolic. For metabolic goals, a separate recommendation in the same guideline (4.4.2) favours metformin over the pill instead. Both sit inside the supplements and medications section.

“Combined” means two hormones in one pill: a synthetic estrogen, almost always ethinylestradiol, and a progestin. Together they do four specific jobs in PCOS.

• Regulate bleeding. They override your own cycle with a fixed one — active pills for two to three weeks, then a scheduled withdrawal bleed. If your natural cycle is unpredictable or absent, this replaces “unpredictable” with “on schedule.”
• Protect the uterine lining. Anovulatory PCOS means estrogen keeps building the endometrium without the progesterone that would normally trigger it to shed. Left unchecked for years, that raises the risk of endometrial hyperplasia. The pill’s progestin sheds the lining on a schedule and removes that risk for as long as you take it. For a one-time bleed rather than ongoing contraception, how to induce a period with PCOS covers the standalone progestin course clinicians use instead.
• Lower circulating free androgens. Estrogen raises sex hormone-binding globulin (SHBG), which binds testosterone and takes it out of circulation. Less free testosterone reaching hair follicles and skin means less new hirsutism and acne over time — not a reversal of hair or scarring that already happened, a slowing of new growth and breakouts.
• Suppress ovarian androgen production directly, on top of the SHBG effect, by switching off the pituitary signal that drives the ovary to make it in the first place.

That same SHBG rise cuts both ways for some people: lower free testosterone helps hirsutism and acne, but it can also reduce vaginal lubrication, since androgens support genital blood flow and tissue thickness alongside oestrogen — why the pill sometimes causes dryness walks through that trade-off and the SHBG data behind it.

Hirsutism and Acne: What the Trial Data Actually Shows

That 1.92-point hirsutism advantage held in only one BMI band — 25 to 30 kg/m² — and the same Cochrane review found the evidence too thin to draw a conclusion above or below it, which is worth knowing if you do not fit that middle range. Ferriman-Gallwey scoring is how trials measure hirsutism, and it is worth knowing the number because “does birth control help hirsutism” gets asked constantly with no figure attached to it.

Acne responds through the same two mechanisms — less free testosterone, less direct ovarian androgen output — but the same Cochrane review did not report a separate acne score, so no PCOS-specific number belongs here; the mechanism is well established, the trial evidence for a precise figure is not. Expect weeks, not days: skin and hair follicles are responding to a lower average androgen exposure, and that shows up over one to three months, not one cycle.

Does Birth Control Cure PCOS?

No drug cures PCOS, and the pill is the clearest example of why. It treats downstream hormonal effects — bleeding pattern, circulating androgens — without touching insulin resistance, the metabolic driver behind ovarian androgen overproduction in most phenotypes. Stop the pill and whatever pattern existed before it tends to return, because the mechanism producing it was never addressed. Weight is a separate, frequently asked question about that same mechanism — does birth control actually cause weight gain with PCOS checks that specific claim against the trial evidence.

You may see PCOS referred to as polyendocrine metabolic ovarian syndrome (PMOS) after a 2026 global consensus of more than 50 organisations renamed it — same condition, same mechanism, only the label changed. This article uses PCOS because that is still what most readers search. If the new name is unfamiliar, PCOS is now PMOS covers what did and did not change.

What Does the Pill Mask?

The pill overrides your hormonal signal on a fixed 28-day schedule, whether or not you ovulated that cycle — which is exactly what it is designed to do, and exactly what makes self-assessment impossible while you are taking it. The withdrawal bleed it produces is not a real menstrual cycle; it is bleeding scheduled by the hormone-free interval. If irregular cycles are one of your two diagnostic features, the pill removes your ability to observe that feature at all.

Bloodwork is affected too. The 2023 guideline notes that anti-Müllerian hormone (AMH) — one of the markers sometimes used alongside ultrasound to support a PCOS diagnosis — is influenced by combined pill use, which is why a hormone panel drawn while you are on it is read with caution rather than taken at face value. Suppressed ovarian androgen output changes testosterone results in the same direction, which is useful for treatment and unhelpful for diagnosis at the same time.

Can You Be Diagnosed With PCOS While Taking It?

Partly. A clinician can still take a history of your cycles from before you started the pill, examine you for hirsutism or acne that predates it, and order an ultrasound — though ovarian suppression from the pill can also affect antral follicle counts, so even imaging is read with that caveat in mind. What a clinician cannot do reliably is diagnose irregular cycles or elevated androgens from bloodwork and cycle pattern collected while you are on it.

This is the practical reason so many people describe being diagnosed only after stopping the pill for an unrelated reason — pregnancy planning, side effects, age — and watching their original teenage symptoms resurface. It is not a failure of the diagnosis or the pill; it is a direct consequence of what the pill is designed to do to your cycle and hormones. What stays assessable while you’re still on it — pre-pill history, existing hirsutism, and metabolic markers — is worth reading before assuming a workup has to wait.

Which Pill? Why the Progestin Matters

Progestins split into two functional groups at the androgen receptor, and a 2017 laboratory comparison found levonorgestrel and gestodene activate the receptor with a potency close to dihydrotestosterone itself, while drospirenone and nomegestrol acetate block it with a potency close to a known clinical anti-androgen drug — meaning “the combined pill” can describe two pharmacologically opposite choices for a symptom like hirsutism.

Cyproterone acetate is not in that assay, but it is the progestin most established in practice as a dedicated anti-androgen — it is prescribed at anti-androgen doses in its own right for severe hirsutism, separate from its use as a pill progestin, and prescribers reach for it or drospirenone first when hyperandrogenism, not cycle regulation, is the main target.

The catch is that anti-androgenic and lower clot risk do not track together. A 2018 meta-analysis, conducted in the general population of healthy combined-pill users rather than in a PCOS cohort, used levonorgestrel pills as the reference point and found gestodene pills carried a relative VTE risk of 1.27 (95% CI 1.15–1.41), cyproterone acetate pills 1.29 (95% CI 1.12–1.49), and desogestrel pills 1.46 (95% CI 1.33–1.59) — and every other progestin tested, drospirenone included, came out above the levonorgestrel baseline, though the size of that gap varied by drug. These are relative risks only; the study reports no absolute incidence for any progestin, and no trial has repeated this comparison in women with PCOS specifically. The absolute risk of a clot on any combined pill is small and depends heavily on the population studied — read the figures above as a comparison between progestins in healthy pill users generally, not as a stated chance of a clot happening to you. The progestin that helps skin and hair growth the most is, on average, not the one with the lowest relative clot risk. That is exactly the trade-off a prescriber is weighing — not a reason to avoid the newer options outright.

Who Should Not Take the Combined Pill

Four things rule it out, all because estrogen raises clotting and blood-pressure risk on top of whatever baseline risk a person already carries.

• Migraine with aura. Estrogen measurably raises ischemic stroke risk in people who already get aura; this is one of the few near-absolute contraindications in the class.
• A personal history of VTE (blood clots). The pill’s own estrogen dose adds to that baseline risk regardless of which progestin it is paired with.
• Smoking, if you are over 35. The combination of estrogen and smoking’s effect on clotting factors is the specific reason for the age cutoff — smoking alone at a younger age is a caution, not always an automatic stop.
• Uncontrolled hypertension. Estrogen can raise blood pressure further, and starting the pill on top of poorly controlled hypertension compounds a cardiovascular risk that is already elevated.

Migraine itself is common enough in PCOS to be worth its own look, separate from the pill decision — migraine, aura, and stroke risk in PCOS covers what distinguishes a routine hormonal headache from the aura pattern above.

What Happens When You Stop?

The hypothalamic-pituitary-ovarian axis typically restarts within a few months of stopping, but PCOS itself does not reset on the same timeline, because the pill was never treating the mechanism behind it. Whatever pattern existed before starting — irregular cycles, hirsutism, acne, or all three — is what most people see return, sometimes within the first cycle, sometimes over a few months as suppressed androgen production returns to its own baseline.

This is also the point at which an actual diagnosis becomes possible, if there was never one. Cycle length, ovulation, and androgen levels can finally be assessed against your own baseline rather than the pill’s schedule.

Who This Isn’t Right For

The combined pill will not help if:

• You are trying to conceive. It is a contraceptive; using it to manage PCOS symptoms and trying to get pregnant are mutually exclusive.
• Insulin resistance is your primary concern. It does not lower insulin, improve insulin sensitivity, or change HOMA-IR. Insulin resistance and PCOS covers what actually moves that marker.
• You need a diagnosis before deciding on long-term management. Starting or continuing the pill before a workup makes that workup harder, not easier, for the reasons above.
• You have migraine with aura, a VTE history, smoke and are over 35, or have uncontrolled hypertension. These are not preferences — they are contraindications.

Your Next Step

Bring three things to the appointment: your cycle history from before you started any hormonal contraception, or a note that you never had a clear picture of it; your family history of blood clots and your own smoking status; and the one symptom you most want addressed — bleeding, hirsutism, acne, or endometrial protection — because that answer changes which progestin is worth discussing first.